Form 8-K HAEMONETICS CORP For: Nov 07

Go back to Form 8-K HAEMONETICS CORP For: Nov 07

Barrington Research Upgrades Haemonetics (HAE) to Outperform

November 8, 2016 9:53 AM EST

Barrington Research upgraded Haemonetics (NYSE: HAE) from Market Perform to Outperform with a price target of $41.00.

For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.

Shares of Haemonetics closed at $36.84 yesterday.

... More

Haemonetics (HAE) Tops Q2 EPS by 11c; Updates on Restructuring

November 7, 2016 8:21 AM EST

Haemonetics (NYSE: HAE) reported Q2 EPS of $0.46, $0.11 better than the analyst estimate of $0.35. Revenue for the quarter came in at $220.25 million versus the consensus estimate of $210.72 million.

RESTRUCTURING AND TURNAROUND EXPENSES AND DEAL AMORTIZATION

The Company announced and has been implementing a turnaround plan to... More